Showing results (1-10 of 6) with videos related to
Sort By:
Pageof 1
Journal of Clinical Pharmacy and Therapeutics|November 23, 2017
Retracted: Influence of genetic variants of IDH1, IDH2, TET2 and DNMT3A on cytarabine cytotoxicity in different populationsY Wang, J K LambaClinical Pharmacology and Therapeutics|October 3, 2000
CYP2C19 genetic mutations in North IndiansJ K Lamba, R K Dhiman, K K KohliClinical Pharmacology and Therapeutics|May 20, 1998
Genetic polymorphism of the hepatic cytochrome P450 2C19 in north Indian subjectsJ K Lamba, R K Dhiman, K K KohliEuropean Journal of Clinical Pharmacology|January 17, 2002
Correlation between omeprazole hydroxylase and CYP2C19 genotype in North IndiansJ K Lamba, R K Dhiman, R Singh, et al.European Journal of Clinical Pharmacology|January 29, 1999
Genetic polymorphism of CYP2D6 in North Indian subjectsV Lamba, J K Lamba, J B Dilawari, et al.British Journal of Cancer|December 5, 2013
SLC28A3 genotype and gemcitabine rate of infusion affect dFdCTP metabolite disposition in patients with solid tumoursA Khatri, B W Williams, J Fisher, et al.Pageof 1